H.C. Wainwright & Co. (@hcwco) 's Twitter Profile
H.C. Wainwright & Co.

@hcwco

#HCWCO provides sector-focused #InvestmentBanking , Equity Research, Sales & Trading, Strategic Advisory and Corporate Access services.

ID: 834417067914838016

linkhttp://www.hcwco.com calendar_today22-02-2017 14:58:26

4,4K Tweet

3,3K Followers

1,1K Following

H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

#Angioedema is swelling underneath the skin. Join #HCWCO at the 1st Annual Hereditary Angioedema (HAE) Virtual Conference on July 20, 2022. Click here to register: bit.ly/3xVcWP7

#Angioedema is swelling underneath the skin. Join #HCWCO at the 1st Annual Hereditary Angioedema (HAE) Virtual Conference on July 20, 2022. Click here to register: bit.ly/3xVcWP7
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

The #HCWCO equity research team delivers insights on a wide range of #CleanTech, Alternative Energy, and Environmental Solutions companies. Review our Clean Tech coverage universe here: bit.ly/3F1q4Ux #ESGinvestors #institutionalinvestors

The #HCWCO equity research team delivers insights on a wide range of #CleanTech, Alternative Energy, and Environmental Solutions companies. Review our Clean Tech coverage universe here: bit.ly/3F1q4Ux

#ESGinvestors #institutionalinvestors
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

June 29th, join us at the #HCWCO Preclinical Cancer Drug Discovery: Emerging Targets and Modalities. bit.ly/3mI2zrj #institutionalinvestor

June 29th, join us at the #HCWCO Preclinical Cancer Drug Discovery: Emerging Targets and Modalities.  bit.ly/3mI2zrj #institutionalinvestor
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

#HCWCO is a #capitalmarkets, analysis-driven, full service #investmentbank. Our expert #investmentbanking team facilitates a diverse range of transactions. Learn more about our capabilities: bit.ly/3vcePCC

#HCWCO is a #capitalmarkets, analysis-driven, full service #investmentbank. Our expert #investmentbanking team facilitates a diverse range of transactions. Learn more about our capabilities: bit.ly/3vcePCC
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

You couldn't attend? Don't worry, visit the #HCWCO Media Room. Find #investorpresentations along with recordings of #KOL events and our Weekly #PsychedelicsPodcast here: bit.ly/2SfRWA7

You couldn't attend? Don't worry, visit the #HCWCO Media Room. Find #investorpresentations along with recordings of #KOL events and our Weekly #PsychedelicsPodcast here: bit.ly/2SfRWA7
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Tomorrow, don't miss the 1st Annual #HCWCO Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond. Click here to register: bit.ly/3awZsNi #psychedelicsinvestors #investors

Tomorrow, don't miss the 1st Annual #HCWCO Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond. Click here to register: bit.ly/3awZsNi #psychedelicsinvestors #investors
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Today is the day. #HCWCO 1st Annual #MentalHealth Conference: Neuropsychiatry, Psychedelics, and Beyond. Click the link to join virtually: bit.ly/3awZsNi

Today is the day. #HCWCO 1st Annual #MentalHealth Conference: Neuropsychiatry, Psychedelics, and Beyond. 

Click the link to join virtually: bit.ly/3awZsNi
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

The #HCWCO #EquityResearch team covers 640+ public companies in Life Sciences & #Healthcare, Metals & Mining, #CleanTech, Technology, Financial Technology & #Cryptocurrency. See our coverage here: bit.ly/32hCBR

The #HCWCO #EquityResearch team covers 640+ public companies in Life Sciences & #Healthcare, Metals & Mining, #CleanTech, Technology, Financial Technology & #Cryptocurrency. 

See our coverage here: bit.ly/32hCBR
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Tomorrow join us for the #HCWCO Preclinical Cancer Drug Discovery: Emerging Targets and Modalities – Virtual Conference. Click the link to register and learn more! bit.ly/3mI2zrj

Tomorrow join us for the #HCWCO Preclinical Cancer Drug Discovery: Emerging Targets and Modalities – Virtual Conference. Click the link to register and learn more! bit.ly/3mI2zrj
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Headquartered in #NewYorkCity & servicing a global client base. Our #HCWCO team has a keen sense of trends across all potential market landscapes: bit.ly/3oatLPp

Headquartered in #NewYorkCity & servicing a global client base. Our #HCWCO team has a keen sense of trends across all potential market landscapes: bit.ly/3oatLPp
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Update on #InflaRx ($IFRX): According to the FDA website, Vilobelimab has been granted Orphan Drug Designation for the treatment of pyoderma gangrenosum. More in the #HCWCO Morning Summary; bit.ly/3sxypaP #HealthcareInvestors

Update on #InflaRx ($IFRX): According to the FDA website, Vilobelimab has been granted Orphan Drug Designation for the treatment of pyoderma gangrenosum. More in the #HCWCO Morning Summary; bit.ly/3sxypaP

#HealthcareInvestors
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Our #corporateaccess team hosts #institutionalinvestor events throughout the year. See our recent and upcoming events here: hcwevents.com

Our #corporateaccess team hosts #institutionalinvestor events throughout the year. See our recent and upcoming events here: hcwevents.com
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Save the date and register! #HCWCO 2nd Annual Ophthalmology Virtual Conference is around the corner. August 17, 2022. Learn more here: bit.ly/2TUxQfJ

Save the date and register! #HCWCO 2nd Annual Ophthalmology Virtual Conference is around the corner. August 17, 2022. Learn more here: bit.ly/2TUxQfJ
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

Join our team of industry and #financialprofessionals. Learn more about a career at #HCWCO here: bit.ly/3wMEfJB #investmentbank

Join our team of industry and #financialprofessionals.  Learn more about a career at #HCWCO here: bit.ly/3wMEfJB #investmentbank
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

We are initiating coverage on @theseusrx ($THRX) which is focused on developing pan-inhibition treatments for gastrointestinal stromal tumors. Read more in the #HCWCO Morning Summary; bit.ly/3sxypaP #HealthcareInvestors

We are initiating coverage on @theseusrx  ($THRX) which is focused on developing pan-inhibition treatments for gastrointestinal stromal tumors. Read more in the #HCWCO Morning Summary; bit.ly/3sxypaP

#HealthcareInvestors
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

We are initiating coverage on NRx Pharmaceuticals ($NRXP) which is focused on therapies for central nervous system disorders and life-threatening respiratory diseases. More in the #HCWCO Morning Summary; bit.ly/3sxypaP #PharmaInvestors

We are initiating coverage on <a href="/NRxPharma/">NRx Pharmaceuticals</a> ($NRXP) which is focused on therapies for central nervous system disorders and life-threatening respiratory diseases. More in the #HCWCO Morning Summary; bit.ly/3sxypaP

#PharmaInvestors
H.C. Wainwright & Co. (@hcwco) 's Twitter Profile Photo

We are initiating coverage on Acumen Pharmaceuticals, Inc. ($ABOS) a clinical-stage company developing a novel disease-modifying approach to Alzheimer's disease. Details in the #HCWCO Morning Summary; bit.ly/3sxypaP #BiopharmaInvestors

We are initiating coverage on <a href="/AcumenPharm/">Acumen Pharmaceuticals, Inc.</a> ($ABOS) a clinical-stage company developing a novel disease-modifying approach to Alzheimer's disease. Details in the #HCWCO Morning Summary; bit.ly/3sxypaP

#BiopharmaInvestors